B-Non Hodgkin Lymphoma
6 clinical trials · Condition
◉ Watch B-Non Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies (NCT03448393) | National Cancer Institute (NCI) | 2018-03-26 |
| Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612) | National Cancer Institute (NCI) | 2014-12-12 |
Track B-Non Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.